Vanguard Global Advisers’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
Vanguard Global Advisers's ATEX Position: Q3 2026 in Review
Vanguard Global Advisers reduced its Anterix (ATEX) stake by 22% in Q3 2026, selling an estimated $217K and leaving 8,490 shares worth $666K. The position accounts for ﹤0.01% of the portfolio, ranked #1953.
Vanguard Global Advisers first reported a position in ATEX in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.12M in Q2 2026. 178 funds tracked by Wall St. Rank hold ATEX as of Q3 2026.
- Vanguard Global Advisers held 8,490 shares of Anterix worth $666K as of Q3 2026.
- Vanguard Global Advisers sold 2,351 Anterix shares in Q3 2026, an estimated $217K.
- Anterix made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1953 holding.
- Vanguard Global Advisers first reported a position in Anterix in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Anterix position peaked at $1.12M in Q2 2026.
- 178 funds tracked by Wall St. Rank held Anterix as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.